Waters Stock Forecast for 2023 - 2025 - 2030
Updated on 04/26/2024
Waters Stock Forecast and Price Target
The average price target of $330.00 for Waters's stock set by two distinguished analysts in recent weeks would represent a potential upside of approximately 7.02% from the last closing price in April, 2024 if reached by the end of the year. This potential increase is based on a high estimate of $350.00 and a low estimate of $300.00. If you're not interested in WAT stock, you may be interested in its competitors.
7.02% Upside
Waters Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Waters's Price has decreased by 100.00%, from $245.80 to $0.00. In the next year, analysts are expecting an increase in Fair Value, predicting it will reach $391.65 – an increase of 100.00%. The Waters forecast is for Fair Value to reach $453.97 or grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MRK Stock Forecast | Merck | Outperform |
2
|
$130.72 | Buy/Sell | $130.51 | 7.10% |
| TMO Stock Forecast | Thermo Fisher Scientific | Outperform |
10
|
$571.73 | Buy/Sell | $591.94 | 7.57% |
| ROG Stock Forecast | Roche Holding | Hold |
16
|
CHF218.80 | Buy/Sell | CHF307.83 | 24.54% |
| DHR Stock Forecast | Danaher | Outperform |
10
|
$245.80 | Buy/Sell | $260.33 | 9.85% |
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$106.86 | Buy/Sell | $118.92 | 18.38% |
Waters Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Waters's Revenue has increased by 24.99%, going from $2.37B to $2.96B. In the next year, analysts are expecting an increase in Revenue, predicting it will reach $3.25B – an increase of 9.95%. The Waters forecast is for Revenue to reach $3.66B or grow by 23.78%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GE Stock Forecast | General Electric | Outperform |
8
|
$161.26 | Buy/Sell | $144.00 | 11.62% |
| 6501 Stock Forecast | Hitachi | Outperform |
4
|
¥13.24k | Buy/Sell | ¥11.29k | 7.29% |
| A Stock Forecast | Agilent Technologies | Outperform |
10
|
$136.37 | Buy/Sell | $138.82 | 11.09% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ILMN Stock Forecast | Illumina | Outperform |
16
|
$121.05 | Buy/Sell | $159.28 | 23.92% |
| BRKR Stock Forecast | Bruker | Outperform |
16
|
$80.59 | Buy/Sell | $73.64 | 12.30% |
| TECH Stock Forecast | Bio-Techne Corp | Buy |
16
|
$62.66 | Buy/Sell | $100.78 | 27.67% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 7701 Stock Forecast | Shimadzu | Outperform |
18
|
¥4.18k | Buy/Sell | ¥5.16k | 24.49% |
| 6951 Stock Forecast | JEOL | Outperform |
18
|
¥6.68k | Buy/Sell | ¥0.00 | 3.31% |
| AWH Stock Forecast | Aspira Women's Health | Hold |
7
|
$3.28 | Buy/Sell | $4.80 | 0.61% |
Waters EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Waters's EBITDA has grown, increasing from $804.97M to $1.04B – a growth of 29.39%. The next year looks promising for Waters, with analysts predicting EBITDA of $1.13B – an increase of 8.96%. Over the next seven years, experts anticipate that Waters's EBITDA will grow at a rate of 28.36%.
Waters EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Waters's EBIT has grown by 28.84%, from $679.61M to $875.63M. For the next year, analysts are expecting EBIT to reach $1.01B – an increase of 15.64%. Over the next seven years, experts predict that EBIT will grow by 38.46%.
Waters EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Waters's EPS has decreased by 100.00%, from $9.05 to $0.00. In the next year, analysts are expecting an increase in EPS, predicting it will reach $14.42 – an increase of 100.00%. The Waters forecast is for EPS to reach $16.71 or grow by 100.00%.
.jpg)